Edition:
United States

GlaxoSmithKline PLC (GSK.N)

GSK.N on New York Stock Exchange

37.70USD
2 Dec 2016
Change (% chg)

$0.27 (+0.72%)
Prev Close
$37.43
Open
$37.54
Day's High
$37.85
Day's Low
$37.47
Volume
813,118
Avg. Vol
674,786
52-wk High
$45.58
52-wk Low
$37.37

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.62 December 3 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 4 9,274.69 9,378.70 9,069.32 10,038.70
Quarter Ending Mar-17 1 9,046.77 9,046.77 9,046.77 --
Year Ending Dec-16 5 34,206.50 35,334.50 33,497.50 37,984.00
Year Ending Dec-17 5 36,595.20 37,274.00 35,653.70 37,852.90
Earnings (per share)
Quarter Ending Dec-16 2 0.62 0.64 0.60 --
Year Ending Dec-16 5 2.57 2.67 2.46 2.52
Year Ending Dec-17 5 2.75 2.87 2.70 --
LT Growth Rate (%) 2 11.75 13.50 10.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 9,184.95 9,928.91 743.96 8.10
Quarter Ending Jun-16 8,366.71 9,210.12 843.41 10.08
Quarter Ending Mar-16 8,564.62 8,716.40 151.78 1.77
Quarter Ending Dec-15 8,920.50 9,617.58 697.08 7.81
Quarter Ending Sep-15 9,344.43 9,374.31 29.88 0.32
Earnings (per share)
Quarter Ending Sep-16 0.74 0.85 0.11 14.86
Quarter Ending Jun-16 0.55 0.69 0.14 25.45
Quarter Ending Mar-16 0.52 0.55 0.03 5.77
Quarter Ending Dec-15 0.49 0.55 0.06 12.24
Quarter Ending Sep-15 0.58 0.70 0.12 20.69

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 9,274.69 9,274.69 9,760.60 9,746.37 10,038.70
Quarter Ending Mar-17 9,046.77 9,046.77 9,046.77 8,947.15 --
Year Ending Dec-16 34,206.50 34,206.50 35,386.50 35,903.10 37,984.00
Year Ending Dec-17 36,595.20 36,595.20 37,566.90 37,977.30 37,852.90
Earnings (per share)
Quarter Ending Dec-16 0.62 0.62 0.62 0.62 --
Year Ending Dec-16 2.57 2.57 2.60 2.61 2.52
Year Ending Dec-17 2.75 2.75 2.77 2.78 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 0 3
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 1 3
Year Ending Dec-17 0 0 1 3
Earnings
Quarter Ending Dec-16 0 0 1 1
Year Ending Dec-16 0 0 2 3
Year Ending Dec-17 0 0 2 2